The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA,“ecstasy”)

AR Green, AO Mechan, JM Elliott, E O'Shea… - Pharmacological …, 2003 - ASPET
The amphetamine derivative (±)-3, 4-methylenedioxymethamphetamine (MDMA, ecstasy) is
a popular recreational drug among young people, particularly those involved in the dance …

Polymorphisms in Human MDR1 (P‐glycoprotein): Recent Advances and Clinical Relevance

C Marzolini, E Paus, T Buclin… - Clinical Pharmacology & …, 2004 - Wiley Online Library
Drug transporters are increasingly recognized to be important to drug disposition and
response. P‐glycoprotein, the encoded product of the human MDR1 (ABCB1) gene, is of …

Co‐administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects

W Mueck, D Kubitza, M Becka - British journal of clinical …, 2013 - Wiley Online Library
Aims The anticoagulant rivaroxaban is an oral, direct F actor X a inhibitor for the
management of thromboembolic disorders. Metabolism and excretion involve cytochrome …

Drug-drug interactions among elderly patients hospitalized for drug toxicity

DN Juurlink, M Mamdani, A Kopp, A Laupacis… - Jama, 2003 - jamanetwork.com
Context Drug-drug interactions are a preventable cause of morbidity and mortality, yet their
consequences in the community are not well characterized. Objective To determine whether …

[HTML][HTML] Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin

I Gouin‐Thibault, X Delavenne, A Blanchard… - Journal of Thrombosis …, 2017 - Elsevier
Essentials• Rivaroxaban and dabigatran are substrates of the P‐glycoprotein (P‐gp)
encoded by the ABCB1 gene.• We tested the effect of ABCB1 polymorphisms and of a P‐gp …

Impact of drug transporter studies on drug discovery and development

N Mizuno, T Niwa, Y Yotsumoto, Y Sugiyama - Pharmacological reviews, 2003 - ASPET
Drug transporters are expressed in many tissues such as the intestine, liver, kidney, and
brain, and play key roles in drug absorption, distribution, and excretion. The information on …

Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)

A Johne, J Brockmöller, S Bauer… - Clinical …, 1999 - Wiley Online Library
Objective Extracts of St John's wort (Hypericum perforatum) are widely used in the treatment
of depression, often as an over‐the‐counter drug. In contrast to its frequent use, knowledge …

Transporters and drug therapy: implications for drug disposition and disease

RH Ho, RB Kim - Clinical Pharmacology & Therapeutics, 2005 - Wiley Online Library
The efficacy of drug therapy results from the complex interplay of multiple processes that
govern drug disposition and response. Most studies to date have focused on the contribution …

Expression and function of efflux drug transporters in the intestine

M Takano, R Yumoto, T Murakami - Pharmacology & therapeutics, 2006 - Elsevier
A variety of drug transporters expressed in the body control the fate of drugs by affecting
absorption, distribution, and elimination processes. In the small intestine, transporters …

[HTML][HTML] Cellular and molecular aspects of drug transport in the kidney

KI Inui, S Masuda, H Saito - Kidney international, 2000 - Elsevier
Cellular and molecular aspects of drug transport in the kidney. The kidney plays an
important role in the elimination of numerous hydrophilic xenobiotics, including drugs …